Denise Carter
Co-Founder, COO & DirectorMs. Denise Carter has been the Chief Operating Officer and Director of Quoin Pharmaceuticals Ltd. since October 28, 2021. She is Co-Founder of Quoin Pharmaceuticals, Inc. since March 2018 and serves as its Director since October 2021. Ms. Carter was an Executive Vice President of Business Development and Corporate Affairs at Innocoll Holdings plc (formerly known as Innocoll AG) (formerly Innocoll GmbH) since 2003. From 2001 to 2003, Ms. Carter was the Vice President of Business Development of the drug delivery division of West Pharmaceuticals, Inc. Ms. Carter served as the President of Innocoll Pharmaceuticals Ltd. She has experience in the pharmaceutical industry, and has held executive Business Development roles for various Drug Delivery companies. She serves as Chief Operating officer and Director at Skinvisible, Inc. since 2018. Prior to joining Innocoll, she served as Vice President Business Development for the Drug Delivery division of West Pharmaceutical Services, responsible for business development, marketing, and project management activities. She has held senior business development positions with Eurand, Cardinal Health, and Fuisz Technologies (Biovail). Ms. Carter earned her MBA from Wharton School of Business, University of Pennsylvania and a B.S. in Chemistry from the College of William and Mary.
Positions
- Company NameQuoin Pharmaceuticals, Ltd.Stock CodeQNRXPositionCo-Founder, COO & Director
